Executive Vice President and President, Interventional Cardiology · Boston Scientific Corp. (BSX)

Kevin Ballinger

A named executive officer of Boston Scientific in every fiscal year CompBrief holds from FY2016 to FY2019. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2019

$3,368,572

Salary $587,382Stock awards $1,598,620

FY2018: $2,841,486

4th of 5 named executive officers at Boston Scientific by FY2019 total.

5 named officers on file for Boston Scientific, FY2019

Kevin Ballinger’s pay file — $29

  • 4 fiscal years of pay, line by line
  • 8 equity grants, each cited to its filing
  • BSX’s disclosed peer group of 14 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Boston Scientific’s whole pay program stands against its peers

  • Boston Scientific’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on BSX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed March 25, 2020 (DEF 14A).

Free

Get Kevin Ballinger’s full pay file as a PDF — free

More than this page: up to 10 years of Kevin’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Kevin Ballinger compensation by year

Boston Scientific Summary Compensation Table · all 4 fiscal years held
In US dollars, as Boston Scientific reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018FY2019
Salary$476,647$543,151$567,362$587,382
Bonus$0$0$0$0
Stock awards$1,015,071$1,316,086$1,337,622$1,598,620
Option awards$324,808$412,493$437,498$474,995
Non-equity incentive$483,000$346,500$448,918$460,205
Pension and deferred compensation$198,808$171,378$4,515$227,357
All other$38,112$18,963$45,571$20,013
Total$2,536,446$2,808,571$2,841,486$3,368,572

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Boston Scientific Corp. DEF 14A filed March 25, 2020, accession 0001047469-20-001770, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Boston Scientific Corp. filed document, accession 0001047469-20-001770. Every figure is read from that document and cited to the page and table it appears in. Filed March 25, 2020.

$2.5M
$2.8M
$2.8M
$3.4M
FY16
FY17
FY18
FY19
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2019 year-end
TypeUnvested unitsValue at year-endExercise price
PSU32,298$1,460,516—
RSU27,246$1,232,064—
PSU23,678$1,070,719—
RSU19,038$860,898—
RSU16,116$728,766—
RSU12,920$584,242—
RSU11,839$535,360—
RSU10,666$482,317—
RSU9,909$448,085—
RSU7,532$340,597—
RSU3,679$166,364—
Option38,337—$40.12

Per the Outstanding Equity Awards at Fiscal Year-End table in Boston Scientific Corp.'s FY2019 proxy; value at the fiscal year-end close, as the company printed it. The 12 largest of 15 award rows shown.

Boston Scientific’s named executive officers, FY2019

as the company reported each
Named executive officerRoleFY2019 total
Michael MahoneyChairman of the Board, President and Chief Executive Officer$15,764,140
Daniel BrennanExecutive Vice President and Chief Financial Officer$4,031,286
Joseph FitzgeraldExecutive Vice President and President, Cardiology$4,025,457
Kevin Ballinger · this pageExecutive Vice President and President, Interventional Cardiology$3,368,572
Edward MackeyExecutive Vice President, Operations$3,198,962

The full Boston Scientific compensation record

free company brief

This page is one person within Boston Scientific's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Boston Scientific proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Boston Scientific's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Kevin Ballinger's compensation dossier · One-time report. No refunds.